The Fibrinogen-to-Albumin Ratio (FAR) Predicts Prognosis in Hepatocellular Carcinoma Patients After Liver Transplantation: Development and Validation of a Novel Nomogram

纤维蛋白原/白蛋白比值(FAR)预测肝细胞癌患者肝移植后的预后:新型列线图的建立与验证

阅读:2

Abstract

INTRODUCTION: Hepatocellular carcinoma (HCC) is a common liver tumor. The fibrinogen-albumin ratio (FAR) combined inflammation and nutrition, may have value in the prognosis assessment of HCC patients undergoing liver transplantation. MATERIALS AND METHODS: A total of 239 patients were enrolled in the study and randomly divided into a training set and a validation set in a 7:3 ratio. The optimal cut-off value of FAR was determined by Maximally Selected Rank Statistics, and univariate and multivariate Cox regression analyses were conducted to evaluate the predictive value of FAR for overall survival (OS) and disease-free survival (DFS) in HCC patients after liver transplantation. RESULTS: FAR had a non-linear relationship with OS and DFS, with the optimal cut-off value being 0.0623. Patients in the high FAR group had significantly poorer prognosis (P < 0.05). Multivariate Cox regression analysis further demonstrated that microvascular invasion and FAR ≥ 0.0623 were independent risk factors for OS and DFS. The prognostic prediction model based on FAR and microvascular invasion had good predictive performance and clinical utility. CONCLUSION: This preoperative FAR is an independent prognostic factor for OS and DFS in HCC patients undergoing liver transplantation. The Nomogram model based on FAR has good predictive performance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。